Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
2.
Int J Ment Health Nurs ; 27(1): 296-302, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-28247580

RESUMO

The aim of the present study was to elucidate what non-pharmacological interventions are applied by nursing staff prior to the administration of psychotropic pro re nata (PRN) medication. Best practices would instruct clinical staff to provide non-pharmacological strategies, such as de-escalation and skills coaching, as the first response to patient distress, anxiety, or agitation. Non-pharmacological strategies might be safer for patients, promote more collaborative relationships, and facilitate greater skills development for managing symptoms. The literature has highlighted that poor documentation of pre-PRN administration interventions has limited our understanding of this practice, but evidence suggests that when this information is available, non-pharmaceutical approaches are not being attempted in the majority of cases. This is troubling given that, while clinically appropriate in some instances, PRN have been subject to criticism and lack critical evidence to support their use. The current study is a continuation of our previous work, which examined the reason, frequency, documentation, and outcome (e.g. effectiveness, side-effects) of PRN medication use at our facility. A chart review was conducted to understand what happens prior to the administration of PRN medication at our facility across all inpatient units over the course of 3 months. Results support previous findings that non-pharmacological interventions are poorly documented by front-line staff and are seemingly used infrequently. The use of these interventions differs by patient presentation (e.g. agitation, insomnia), and most often include supportive measures. The findings suggest that both documentation and intervention practices of nursing staff require further investigation and adjustment to align with best practices.


Assuntos
Transtornos Mentais/terapia , Psicotrópicos/uso terapêutico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Agressão/efeitos dos fármacos , Agressão/psicologia , Ansiedade/tratamento farmacológico , Ansiedade/terapia , Feminino , Hospitais Psiquiátricos , Humanos , Masculino , Transtornos Mentais/tratamento farmacológico , Pessoa de Meia-Idade , Agitação Psicomotora/tratamento farmacológico , Agitação Psicomotora/terapia , Transtornos Psicóticos/tratamento farmacológico , Transtornos Psicóticos/terapia , Psicotrópicos/administração & dosagem , Estudos Retrospectivos , Distúrbios do Início e da Manutenção do Sono/tratamento farmacológico , Distúrbios do Início e da Manutenção do Sono/terapia , Adulto Jovem
3.
Int J Ment Health Nurs ; 26(4): 402-408, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27804222

RESUMO

Pro re nata (PRN), a Latin phrase meaning 'as needed', is used to describe medications that might be used in specific situations, in addition to regularly-scheduled medications, such as when a patient is particularly anxious, experiencing insomnia, or suffering pain. While helpful in some circumstances, PRN are associated with an increased risk of morbidity, overuse, dependence, and polypharmacy. There is also a dearth of medical literature describing current practices and trends of PRN administration in mental health facilities, especially in Canada, and the literature that does exist is limited by poor documentation practices. Therefore, the primary objective of the current study was to understand the reason (purpose), frequency, use, documentation practices, and outcome (i.e. effectiveness, side-effects) of PRN medication use on inpatient units. Data were pulled to capture a snapshot of PRN administrations over a 3-month period, and included information related to the administration of the PRN medication, such as time of administration, type and dose of PRN medication, and prescribed indication, as well as patient-specific information. Results indicated that approximately 8200 psychotropic PRN medications were administered during the designated 3-month time period, and over 90% of patients received at least one PRN. Most of these were benzodiazepines, followed by antipsychotics. Further analyses were conducted to determine other characteristics of PRN use patterns and to provide a baseline of understanding that will inform future research to investigate the practice of PRN administration to psychiatric inpatients.


Assuntos
Hospitais Psiquiátricos/estatística & dados numéricos , Preparações Farmacêuticas/administração & dosagem , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Canadá , Feminino , Humanos , Hipnóticos e Sedativos/administração & dosagem , Masculino , Transtornos Mentais/tratamento farmacológico , Pessoa de Meia-Idade , Psicotrópicos/administração & dosagem , Distúrbios do Início e da Manutenção do Sono/tratamento farmacológico , Resultado do Tratamento , Adulto Jovem
4.
Sultan Qaboos Univ Med J ; 12(3): 286-94, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23269949

RESUMO

Dyslexia is a specific learning disability that is neurological in origin, with an estimated overall worldwide prevalence of 5-10% of the population. It is characterised by difficulties in reading, accuracy, fluency, spelling and decoding abilities. The majority of publications reviewed indicated that screening is performed at the preschool level. Screening can also be conducted at birth or the first year of life. Understanding human development theory, for example, Piaget's human development theory, may help determine at which stage of childhood development dyslexia is more detectable, and therefore guide the management of this disability. The objective of this review is to provide a brief and updated overview of dyslexia and its management in children through human development issues.

5.
Sultan Qaboos Univ Med J ; 11(4): 511-4, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22087402

RESUMO

We report a confirmed case of cannabis exposure in an Omani female child with developmental delay. Cannabis exposure in children can lead to many consequences; for example, chronic use can result in developmental delay, abnormal behaviour, and hyperactivity while there is a risk of coma with acute exposure. It is important for clinicians to consider substance abuse as a differential diagnosis for similar presentations in paediatric patients, noting that children are at risk of cannabis exposure if their parents/caregivers are cannabis users.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA